Bafilomycin A1 |
V115-905 |
88899-55-2 |
C35H58O9 |
>98% (HPLC); NMR (conforms) |
(-)-Bafilomycin A1 |
Camostat Mesilate |
S565-906 |
59721-29-8 |
C20H22N4O5 • CH3SO3H |
>98% (HPLC); NMR (Conforms) |
4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate, methanesul-fonic acid salt;
FOY-305; Foipan |
Captopril |
A51-906 |
62571-86-2 |
C9H15NO3S |
>98% (HPLC, TLC); NMR (conforms) |
(2S)-1-(3-mercapto-2-methyl-propionyl)-L-proline |
Chloroquine phosphate |
C119-905 |
50-63-5 |
C18H26ClN3 · 2H3PO4 |
>98% (TLC); NMR (conforms) |
N4-(7-Chloro-4-quinolinyl)-N1,N1-dimethyl-1,4-pentanediamine, diphosphate |
Hydroxychloroquine |
T860-905 |
747-36-4 |
C18H26ClN3O · H2SO4 |
>98% (TLC); NMR (conforms) |
7-Chloro-4-[4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]quinoline, sulfate. |
INK-128 |
F17-901C |
|
C15H15N7O |
|
|
Losartan potassium |
S35-908 |
124750-99-8 |
C22H22ClN6O · K |
>99% (TLC); NMR (conforms) |
2-Butyl-4-chloro-1-{[2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl]methyl}-1H-imidazole-5-methanol, potassium salt (DUP-753) |
Mycophenolic acid |
I23-905 |
24280-93-1 |
C17H20O6 |
>98% (HPLC); NMR (conforms) |
6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexanoic acid; NSC129185 |
Niclosamide |
S54-900 |
50-65-7 |
C13H8Cl2N2O4 |
>98% (TLC); NMR (conforms) |
5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide |
Nitazoxanide |
P312-905 |
55981-09-4 |
C12H9N3O5S |
>98% (HPLC); NMR (conforms) |
O-[N-(5-Nitrothiazol-2-yl)carbamoyl]phenyl acetate; NTZ |
Ponatinib |
A03-900 |
943319-70-8 |
C29H27F3N6O |
>98% (HPLC); NMR (Conforms) |
3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide; AP-24534 |
RVX-208 |
B17-905B |
1044870-39-4 |
C20H22N2O5 |
>98% (TLC); NMR (conforms) |
2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-4(3H)-quinazolinone |
Tofacitinib |
J01-900 |
477600-75-2 |
C16H20N6O |
>99% (HPLC/TLC); NMR (Conforms) |
|
Valinomycin |
V113-908 |
2001-95-8 |
C54H90N6O18 |
>98% (HPLC); NMR (conforms) |
Cyclo(D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl) |
Verapamil HCl |
V114-908 |
152-11-4 |
C27H38N2O4 · HCl |
>98% (TLC); NMR (conforms) |
α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)benzeneacetonitrile, hydrochloride |